NAUT — Nautilus Biotechnology Share News
0.000.00%
- $412.31m
- $328.28m
Brief: Nautilus Biotechnology Appoints Gwen Weld As Chief People Officer
Brief: Nautilus Biotechnology Reports Fourth Quarter And Fiscal Year 2021 Financial Results
Brief: Nautilus And Abcam Announce Strategic Partnership To Accelerate Exploration Of The Proteome
Brief: Nautilus Biotechnology Reports Second Quarter 2021 Financial Results
NASDAQ RESUMED AT 12:51 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:46 PM
NASDAQ RESUMED AT 12:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:31 PM
NASDAQ RESUMED AT 12:30 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:25 PM
Arya Sciences Acquisition: Doubles on deal to take Nautilus public
Brief: ARYA Sciences Says Nautilus Biotechnology To List On Nasdaq Through Merger With Co
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:59 AM
Brief: Arya Sciences Acquisition Corp III Announces Pricing Of $130 Mln Initial Public Offering
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 01:27 PM